1.
Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and Pharmacology
by Knouff, Chris
Endocrine reviews, 2004-12, Vol.25 (6), p.899-918
2.
Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones
by Lu, Min
Nature medicine, 2011-05, Vol.17 (5), p.618-622
3.
A role for central nervous system PPAR-γ in the regulation of energy balance
by Ryan, Karen K
Nature medicine, 2011-05, Vol.17 (5), p.623-626
4.
Smooth Muscle Peroxisome Proliferator–Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo
by Hasan, David M
Hypertension (Dallas, Tex. 1979), 2015-07, Vol.66 (1), p.211-220
5.
PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage
by Vasheghani, Faezeh
Annals of the rheumatic diseases, 2015-03, Vol.74 (3), p.569-578
6.
Antagonism of PPAR-γ signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis
by Guo, Bin
Nature medicine, 2018-03, Vol.24 (3), p.360-367
7.
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia
by Matias, Isabel
The journal of clinical endocrinology and metabolism, 2006-08, Vol.91 (8), p.3171-3180
8.
PEDF and 34-mer inhibit angiogenesis in the heart by inducing tip cells apoptosis via up-regulating PPAR-γ to increase surface FasL
by Zhang, Hao
Apoptosis (London), 2015-10-30, Vol.21 (1), p.60-68
9.
PPAR-γ regulates osteoclastogenesis in mice
by Evans, Ronald M
Nature medicine, 2007-12, Vol.13 (12), p.1496-1503
10.
Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression
by Cao, Liang-qi
Cancer letters, 2015, Vol.359 (1), p.127-135
11.
The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Aci...
by Barroso, Emma
Endocrinology (Philadelphia), 2011-05, Vol.152 (5), p.1848-1859
12.
CXCL9 and CXCL11 Chemokines Modulation by Peroxisome Proliferator-Activated Receptor-α Agonists Secretion in Graves’ and Normal Thyrocytes
by Antonelli, Alessandro
The journal of clinical endocrinology and metabolism, 2010-12, Vol.95 (12), p.E413-E420
13.
Mechanical Loading Down-Regulates Peroxisome Proliferator-Activated Receptor γ in Bone Marrow Stromal Cells and Favors Osteoblastogenesis at the Expense of Adipogenesis
by David, Valentin
Endocrinology (Philadelphia), 2007-05, Vol.148 (5), p.2553-2562
14.
Peroxisome Proliferator-Activated Receptor-α Control of Lipid and Glucose Metabolism in Human White Adipocytes
by Ribet, Carole
Endocrinology (Philadelphia), 2010-01, Vol.151 (1), p.123-133
15.
Peroxisome-Proliferator Receptor γ Represses Hepatic Sex Hormone-Binding Globulin Expression
by Selva, David M
Endocrinology (Philadelphia), 2009-05, Vol.150 (5), p.2183-2189
16.
A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses
by Wei, Jun
Annals of the rheumatic diseases, 2014-02, Vol.73 (2), p.446-454
17.
Bisphenol S Induces Adipogenesis in Primary Human Preadipocytes From Female Donors
by Boucher, Jonathan G
Endocrinology (Philadelphia), 2016-04, Vol.157 (4), p.1397-1407
18.
Environmental Obesogens: Organotins and Endocrine Disruption via Nuclear Receptor Signaling
by Grün, Felix
Endocrinology (Philadelphia), 2006-06, Vol.147 (6), p.s50-s55
19.
Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice
by Shan, Tizhong
Diabetologia, 2016-06-13, Vol.59 (9), p.1995-2004
20.
Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity
by Diano, Sabrina
Nature medicine, 2011-08-28, Vol.17 (9), p.1121-1127
